This excerpt taken from the GXDX 8-K filed Apr 30, 2009.
Revised 2009 Performance Outlook
For the full-year 2009, Genoptix expects revenues of between $170 to $175 million, up from previous expectations of approximately $170 million, with gross margins in the high-fiftieth percentile.
Operating margins for 2009 are expected to be in the low-twentieth percentile, while net income is expected to be approximately $22 million, up from prior estimates of $21 million. Diluted EPS for the full-year 2009 is increasing from approximately $1.15 and is now expected to be between $1.20 to $1.25 on approximately 18.1 million shares assuming a tax rate of 45% in the Companys first year operating as a fully-taxed entity.
Based on continued infrastructure expansion and implementation of its strategic plan, the Company projects capital expenditures of approximately $8 million for the full-year 2009, which includes approximately $4.5 million in maintenance capital.